| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/19/2009 | US20090048173 Use Of Dipyridamole For Treatment Of Resistance To Platelet Inhibitors |
| 02/19/2009 | US20090048171 Treatment of viral infections |
| 02/19/2009 | US20090048159 Kit for treating a health condition by inducing translocation of a calreticulin protein to a cellular membrane |
| 02/19/2009 | US20090048156 Hdac inhibitors and hormone targeted drugs for the treatment of cancer |
| 02/19/2009 | US20090048155 Methods for preventing and treating tissue injury and sepsis associated with Yersinia pestis infection |
| 02/19/2009 | US20090048154 Compositions and Methods for Treating Diabetes |
| 02/19/2009 | US20090048153 Composition for treating sulfur mustard toxicity and methods of using same |
| 02/19/2009 | US20090048151 PEG-Poly(Ortho Ester) Graft Copolymers and Pharmaceutical Compositions |
| 02/19/2009 | US20090048148 Compositions and methods for therapeutic use |
| 02/19/2009 | US20090047753 Scaffold-organized clusters and electronic devices made using such clusters |
| 02/19/2009 | US20090047687 Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents, Intermediates, and Method of Preparation |
| 02/19/2009 | US20090047654 Polymer affinity matrix, a method for the production and use thereof |
| 02/19/2009 | US20090047371 Pharmaceutical composition comprising curcumin and resveratrol and uses thereof in medical field |
| 02/19/2009 | US20090047370 Topical treatment of peripheral neuropathy |
| 02/19/2009 | US20090047369 Composition Comprising 4-Carbon Dicarboxlic Acids for Improvement of Memory Function |
| 02/19/2009 | US20090047368 Polymeric polyphenol extracted from fermented tea, therapeutic agent for mitochondrial disease, preventive/therapeutic agent for diabetes mellitus, and food or beverage |
| 02/19/2009 | US20090047365 Novel Concomitant Use of Sulfonamide Compound with Anti-Cancer Agent |
| 02/19/2009 | US20090047361 Combination of Limited Nutrients and Enhanced Dietary Antioxidants To Impart Improved Kidney Health |
| 02/19/2009 | US20090047358 Phospholipid-based powders for drug delivery |
| 02/19/2009 | US20090047357 Method of producing drug-containing wax matrix particles, extruder to be used in the method and sustained-release preparation containing cilostazol |
| 02/19/2009 | US20090047355 Process for producing pulverulent phytosterol formulations |
| 02/19/2009 | US20090047354 process for the preparation of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl) ethyl)-6-chloro-1, 3-dihydro-2h-indol-2-one hydrochloride (ziprasidone hydrochloride) and its intermediate |
| 02/19/2009 | US20090047351 Processes For Making Lactose Utilizing Pre-Classification Techniques And Pharmaceutical Formulations Formed Therefrom |
| 02/19/2009 | US20090047350 Perforated water soluble polymer based edible films |
| 02/19/2009 | US20090047348 Poly(organophosphazene) hydrogels for drug delivery, preparation method thereof and use thereof |
| 02/19/2009 | US20090047347 Compositions for Drug Administration |
| 02/19/2009 | US20090047346 Sustained release formulations of sotalol |
| 02/19/2009 | US20090047344 Formulations |
| 02/19/2009 | US20090047343 Method for stabilizing phenylephrine |
| 02/19/2009 | US20090047342 Methods of Treating Infectious Diseases |
| 02/19/2009 | US20090047338 Method to Treat Flavivirus Infection with siRNA |
| 02/19/2009 | US20090047337 Method of administering a cationic liposomal preparation |
| 02/19/2009 | US20090047336 novel formulation of dehydrated lipid vesicles for controlled release of active pharmaceutical ingredient via inhalation |
| 02/19/2009 | US20090047330 Oral fast dissolving films for erectile dysfunction bioactive agents |
| 02/19/2009 | US20090047328 Caffeine delivery systems |
| 02/19/2009 | US20090047324 Medical Devices Containing Rapamycin Analogs |
| 02/19/2009 | US20090047323 Medical Devices Containing Rapamycin Analogs |
| 02/19/2009 | US20090047321 Antimicrobial compounds having protective or therapeutic leaving groups |
| 02/19/2009 | US20090047320 Apparatus and Method for Reducing the Occurrence of Post-Surgical Adhesions |
| 02/19/2009 | US20090047319 Pharmaceutical composition for obstructive vascular disease |
| 02/19/2009 | US20090047318 Nanoparticle-coated medical devices and formulations for treating vascular disease |
| 02/19/2009 | US20090047308 Gradient copolymer, composition including same and cosmetic make-up or care method |
| 02/19/2009 | US20090047307 Chemo-Immunotherapy Method |
| 02/19/2009 | US20090047306 Adjuvant compositions |
| 02/19/2009 | US20090047305 Method of producing proanthocyanidin oligomer |
| 02/19/2009 | US20090047304 Composition For Body Fat Reduction |
| 02/19/2009 | US20090047299 Modified alpha-galactosyl ceramides for staining and stimulating natural killer t cells |
| 02/19/2009 | US20090047295 Methods and Compositions for Reducing Stemness in Oncogenesis |
| 02/19/2009 | US20090047294 Inhibitors of prolyl-hydroxylase 1 for the treatment of skeletal muscle degeneration |
| 02/19/2009 | US20090047292 Graft rejection suppressors |
| 02/19/2009 | US20090047288 Glucan compositions and methods of enhancing CR3 dependent neutrophil-mediated cytotoxicity |
| 02/19/2009 | US20090047287 Modulation of bone formation |
| 02/19/2009 | US20090047286 H2n3 influenza a viruses and methods of use |
| 02/19/2009 | US20090047283 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 02/19/2009 | US20090047282 Prophylactic/Therapeutic Agent for Cancer |
| 02/19/2009 | US20090047279 (R)-N-Stereoisomers of 7,8-Saturated-4,5-Epoxy-Morphinanium Analogs |
| 02/19/2009 | US20090047278 Novel Combinational Use of Sulfonamide Compound |
| 02/19/2009 | US20090047276 Methods for increasing cell or tissue regeneration in a vertebrate subject |
| 02/19/2009 | US20090047275 Modulating calvarial osteoblast differentiation; fracture repair |
| 02/19/2009 | US20090047274 Diagnostic and therapeutic target cdc2l6 proteins for neurodegenerative diseases |
| 02/19/2009 | US20090047259 Methods of Using the Calcineurin A Variant CnA-beta 1 |
| 02/19/2009 | US20090047256 Biodegradable Elastomers |
| 02/19/2009 | US20090047254 Bacteriophage and their uses |
| 02/19/2009 | US20090047252 Antiviral compounds |
| 02/19/2009 | US20090047250 Methods for treating or preventing neuroinflammation or autoimmune diseases |
| 02/19/2009 | US20090047249 Modulators of toll-like receptor 7 |
| 02/19/2009 | US20090047248 Triazolyl macrocyclic hepatitis c serine protease inhibitors |
| 02/19/2009 | US20090047247 Pyrrolidine Derivatives |
| 02/19/2009 | US20090047246 Novel inhibitors of hepatitis c virus replication |
| 02/19/2009 | US20090047245 Prognostic chronic hepatitis C biomarkers |
| 02/19/2009 | US20090047244 Macrocyclic serine protease inhibitors i |
| 02/19/2009 | US20090047243 Combinations for the treatment of b-cell proliferative disorders |
| 02/19/2009 | US20090047240 Chaperonin 10-induced immunomodulation |
| 02/19/2009 | US20090047238 Novel Spirotropane Compounds And Methods For The Modulation Of Chemokine Receptor Activity |
| 02/19/2009 | US20090047234 Compositions for nasal delivery |
| 02/19/2009 | US20090047233 Method for removing Phosphate and Polymer Used Therefore |
| 02/19/2009 | US20090047224 Cosmetic Process for Preventing or Treating the Signs of Skin Ageing or the Orange-Peel Appearance |
| 02/19/2009 | US20090047221 Compounds and compositions useful in the treatment of neoplasia |
| 02/19/2009 | US20090047217 Polynucleotides Encoding Members of the Human B Lymphocyte Activation Antigen B7 Family and Polypeptides Encoded Thereby |
| 02/19/2009 | US20090047214 Novel methylation marker |
| 02/19/2009 | US20090047209 Novel nifedipine compositions |
| 02/19/2009 | US20090046841 Telecommunication call management and monitoring system with voiceprint verification |
| 02/19/2009 | DE102007038957A1 6-Thioxo-pyridazinderivate 6-thioxo-pyridazine derivatives |
| 02/19/2009 | DE102007038849A1 Verwendung von R(+)-alpha-Liponsäure zur Behandlung der kryptogenen Neuropathie Use of R (+) - alpha-lipoic acid for the treatment of neuropathy cryptogenic |
| 02/19/2009 | DE102007038251A1 Neues Herstellverfahren New manufacturing process |
| 02/19/2009 | DE102007038250A1 Neues Herstellverfahren New manufacturing process |
| 02/19/2009 | DE102007038097A1 Tyrosinaseinhibitoren Tyrosinase |
| 02/19/2009 | DE102007037579A1 Neue Benzimidazol-2-yl-alkylamine und ihre Anwendung als mikrobizide Wirkstoffe New benzimidazol-2-yl-alkylamines and their application as microbicidal agents |
| 02/19/2009 | DE102007037373A1 New oxazolidinone derivatives are factor Xa inhibitors useful to treat e.g. acute coronary syndrome, myocardial infarction, angina pectoris, reocclusion, restenosis, stroke, artrial fibrillation, arrhythmia and blood clotting disorder |
| 02/19/2009 | DE102004014637B4 Nicht-metabolisierbares Aminosäureanalogon Non-metabolizable amino acid analogue |
| 02/19/2009 | CA2826272A1 Anti-angiogenic agents and methods of use |
| 02/19/2009 | CA2820566A1 Dhea compositions for treating menopause |
| 02/19/2009 | CA2733706A1 Modulation of immune responses by administration of roxithromycin or its derivative |
| 02/19/2009 | CA2733681A1 A composition based on perhydrosqualene and collagen-polyvinylpyrrolidone for filling minor cutaneous depressions |
| 02/19/2009 | CA2733676A1 Microrna compositions and methods for the treatment of myelogenous leukemia |
| 02/19/2009 | CA2708320A1 Amide derivatives as trpv1 antagonists |
| 02/19/2009 | CA2705463A1 Anti-inflammatory compounds and uses thereof |
| 02/19/2009 | CA2702292A1 Bicyclic amides for ehancing glutamatergic synaptic responses |
| 02/19/2009 | CA2696630A1 Rna sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles |
| 02/19/2009 | CA2696558A1 Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivative |